- Product Details
Keywords
- Doravirine
- MK-1439
- MK1439
Quick Details
- ProName: Doravirine
- CasNo: 1338225-97-0
- Molecular Formula: C17H11ClF3N5O3
- Application: API
- ProductionCapacity: Metric Ton/Day
- Purity: 98%
- LimitNum: 0 Metric Ton
Superiority
Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor under development for use in the treatment of HIV/AIDS. Doravirine demonstrated robust antiviral activity and good tolerability in a small clinical study of 7-day monotherapy reported at the 20th Conference on Retroviruses and Opportunistic Infections in March 2013. Doravirine appeared safe and generally well tolerated with most adverse events being mild-to-moderate.